Samantha Shenoy, MS, MSN, ACNP-BC: Long-term Follow-up Results from CARTITUDE-1 Study and How APPs Can Educate Patients About the Data Effectively

November 19, 2025

Samantha Shenoy, MS, MSN, ACNP-BC, provides findings on the long-term follow-up data from CARTITUDE-1 for ciltacabtagene autoleucel. She stressed the importance of this being a one-and-done therapy where patients can remain in remission for years and return to their regular lives, and how APPs can educate their patients who are eligible for this treatment.

MORE EXPERT PERSPECTIVES IN MULTIPLE MYELOMA:

Mary Steinbach, DNP, APRN, and Eliza Parkin, NP: Addressing the Safety Profile of Multiple Myeloma Therapy

Mary Steinbach, DNP, APRN, and Eliza Parkin, NP, discuss the importance of educating patients about the safety profile of multiple myeloma treatment and how to guide patients through adverse events.

Mary Steinbach, DNP, APRN, and Eliza Parkin, NP: Instilling Confidence in NPs when Communicating with their Patients about Multiple Myeloma Treatment

Mary Steinbach, DNP, APRN, and Eliza Parkin, NP, discuss the importance of having confidence when providing care for patients with multiple myeloma. They provide tips on how to increase confidence and knowledge regarding multiple myeloma treatment.